Niceritrol
CAS No. 5868-05-3
Niceritrol ( Bufor; Cardiolipol; Perycit )
Catalog No. M27179 CAS No. 5868-05-3
Niceritrol is a niacin ester that reduces cholesterol and triglycerides in total plasma and in the VLD and LD lipoprotein fractions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 69 | Get Quote |
|
5MG | 100 | Get Quote |
|
10MG | 142 | Get Quote |
|
25MG | 255 | Get Quote |
|
50MG | 383 | Get Quote |
|
100MG | 566 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNiceritrol
-
NoteResearch use only, not for human use.
-
Brief DescriptionNiceritrol is a niacin ester that reduces cholesterol and triglycerides in total plasma and in the VLD and LD lipoprotein fractions.
-
DescriptionNiceritrol is a niacin ester that reduces cholesterol and triglycerides in total plasma and in the VLD and LD lipoprotein fractions.
-
SynonymsBufor; Cardiolipol; Perycit
-
PathwayOthers
-
TargetOther Targets
-
RecptorCathepsin L; P. falciparum
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5868-05-3
-
Formula Weight556.5
-
Molecular FormulaC29H24N4O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(OCC(COC(=O)c1cccnc1)(COC(=O)c1cccnc1)COC(=O)c1cccnc1)c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shah PP, et al. Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L. Mol Pharmacol. 2008 Jul;74(1):34-41.
molnova catalog
related products
-
PMEDAP
PMEDAP is a potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality and an inhibitor of human immunodeficiency virus (HIV) replication. PMEDAP also has anti-murine cytomegalovirus (MCMV) activity.
-
Tau protein (592-597...
Tau protein (592-597), Human (TFA) is a peptide fragment of human Tau protein.
-
Ranolazine
Ranolazine is a calcium uptake inhibitor via the sodium/calcium channel, used to treat chronic angina.